ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0407

Prevalence of Autoimmune Diseases in 8244 Family Members of Children with Juvenile Idiopathic Arthritis: A Study from India

Lekshmi Minikumari Rahulan1, Able Lawrence2 and Amita Aggarwal3, 1Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, 2SGPGIMS, Lucknow, Lucknow, Uttar Pradesh, India, 3Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, Lucknow, Uttar Pradesh, India

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, Juvenile idiopathic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Pediatric Rheumatology – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Familial aggregation of autoimmune disease as well as co-occurrence of multiple autoimmune diseases in one individual is known and it suggests a shared genetic basis for autoimmunity. Though there is significant data available on familial aggregation of autoimmune diseases in adult rheumatic diseases, the data in JIA is limited1,2 and is scant from South Asia. In South Asia, enthesitis related arthritis (ERA) is the commonest category of JIA. We looked at the prevalence of autoimmune diseases among family members of children with JIA.

Methods: Families of patients with JIA who satisfied the ILAR classification criteria for JIA were enrolled in the study after obtaining a written informed consent. They were asked about the history of autoimmune diseases in the patient as well as among the first, second and third degree relatives, with the help of a questionnaire. The presence of autoimmune disease was confirmed from medical records, prescriptions or telephonic conversations with patients or relatives where ever possible (Figure 1).

Results: 8244 relatives of 361 patients with JIA (median age of 18 years, duration of disease 6 years, JADAS 7.95; 280 males) and 1033 relatives of 71 healthy children were included in the study. There were more female relatives in both groups. The distribution of JIA categories was: 267 ERA, 31 polyarticular RF+ JIA, 24 sJIA, 14 psoriatic arthritis, 13 polyarticular RF negative JIA and 12 oligoarticular JIA (Table 1). Seven (1.93%) JIA patients had another coexisting autoimmune disease.

210 (58%) children with JIA had at least one relative with an autoimmune disease whereas among healthy children, 15 (22.5 %) had a relative with autoimmune disease (p< 0.001). The proportion of patients with positive family history varied from 16 to 66% in different categories of JIA. (Table 1) Spondyloarthropathy & JIA were the common autoimmune disease among relatives of JIA patients especially so in children with ERA. In non-ERA hypothyroidism followed by RA were common. (Table 1)

The prevalence of autoimmune disease was higher in first degree relatives as compared to second degree relatives (130/1639 versus 97/4421; p< 0.001). Among JIA, 2.5% maternal relatives had an autoimmune disease as opposed to 1.9% paternal relatives (p< 0.001). There was a higher prevalence of spondyloarthropathy among paternal relatives as compared to maternal relatives (1.1% versus 0.7%. p< 0.05). The prevalence of autoimmune diseases among maternal and paternal relatives of controls were 2.3% and 1.2% respectively.

 

Conclusion: More than half of the children with JIA have family members with autoimmune disease suggesting shared genetic basis of JIA. Screening of relatives of JIA may help in early recognition of autoimmune disease in community.

Supporting image 1

Work flowchart

Supporting image 2

JIA categories and occurrence of autoimmune diseases in family members

Supporting image 3

Autoimmune diseases in family members


Disclosures: L. Minikumari Rahulan: None; A. Lawrence: None; A. Aggarwal: None.

To cite this abstract in AMA style:

Minikumari Rahulan L, Lawrence A, Aggarwal A. Prevalence of Autoimmune Diseases in 8244 Family Members of Children with Juvenile Idiopathic Arthritis: A Study from India [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/prevalence-of-autoimmune-diseases-in-8244-family-members-of-children-with-juvenile-idiopathic-arthritis-a-study-from-india/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-autoimmune-diseases-in-8244-family-members-of-children-with-juvenile-idiopathic-arthritis-a-study-from-india/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology